Skip to main content
BIOBIJOU Co., Ltd. logo

BIOBIJOU Co., Ltd. — Investor Relations & Filings

Ticker · 489460 ISIN · KR7489460006 KO Manufacturing
Open in API
Filings indexed 32 across all filing types
Latest filing 2026-06-01 Transaction in Own Shar…
Country KR South Korea
Listing KO 489460

About BIOBIJOU Co., Ltd.

http://www.biobijou.co.kr/eng/

BIOBIJOU Co., Ltd. is a biotechnology company that researches, develops, manufactures, and distributes medical aesthetic and healthcare products. The company's portfolio primarily consists of hyaluronic acid (H.A.)-based dermal fillers, injectable skin boosters, fat-dissolving solutions, and a range of cosmetic skincare items. BIOBIJOU operates across the entire value chain, from initial product development to global sales, employing automated production facilities and rigorous quality control systems. The company serves a global market, with an established international sales network and a significant distribution presence in China. It focuses on technological research and development to provide stable and high-quality products for the skincare and wellness sectors.

Recent filings

Filing Released Lang Actions
주요사항보고서(자기주식취득결정)
Transaction in Own Shares Classification · 85% confidence The document is a ‘주요사항보고서’ (major event report) detailing the decision to acquire treasury shares, including planned share count, periods, purposes, methods, and limits. This is a share buyback announcement. Under the specified taxonomy, a report on share repurchase falls under “Transaction in Own Shares” (POS).
2026-06-01 Korean
기업설명회(IR)개최
Regulatory Filings Classification · 75% confidence The document is a notice of an upcoming corporate investor relations (IR) presentation event, detailing date, time, venue, target audience, purpose, method, content, sponsors, contact details, and where IR materials will be posted. It does not contain the actual presentation slides, financial statements, or substantive report content, nor is it a proxy or dividend notice. It is a general regulatory announcement of an IR event, which best fits under the fallback category “Regulatory Filings” (RNS).
2026-05-20 Korean
분기보고서 (2026.03)
Interim / Quarterly Report Classification · 98% confidence The document is clearly titled “분기보고서” (Korean for ‘Quarterly Report’) covering the period January 1, 2026 to March 31, 2026 (Q1 of the 9th fiscal year). It contains extensive financial tables, company overview, capital/stock data and business performance metrics for the quarter – this is the full quarterly/interim report itself, not a brief announcement or certification. According to the filing definitions, this matches an Interim / Quarterly Report (IR). Q1 2026
2026-05-14 Korean
기업가치제고계획(자율공시)
Regulatory Filings Classification · 75% confidence The document is a voluntary corporate value enhancement plan (“기업가치 제고 계획(자율공시)”) containing forward‐looking business targets, R&D and dividend policy details. It is not an earnings release (no financial results), not a board or management change notice, not a specific financing or share issuance, nor any other narrowly defined category. It is a general regulatory disclosure made under Korean voluntary disclosure rules and therefore falls into the fallback category ‘Regulatory Filings’.
2026-04-17 Korean
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements Classification · 92% confidence The document is the official result of a regular shareholders’ meeting (AGM) held on March 31, 2026, showing detailed agenda items, vote counts, approval status for financial statements, dividends, director and auditor appointments, and vote percentages. This corresponds to a Declaration of Voting Results & Voting Rights Announcement (DVA).
2026-03-31 Korean
감사보고서제출
Audit Report / Information Classification · 92% confidence The document is titled “감사보고서 제출” (Submission of Audit Report) and contains auditor’s opinions on consolidated and separate financial statements, key financial metrics, the auditor’s name, and the audit report receipt date. It does not include a full annual report format or investor presentation, nor is it merely a notice of publication. It is a standalone audit report submission. Therefore, it fits the Audit Report / Information category. FY 2025
2026-03-23 Korean

Browse filings by year

4 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.